The Virginia G. Piper Center for Personalized Diagnostics announced that Joshua LaBaer will be the center's new director. Most recently, LaBaer served as director of the Harvard Institute of Proteomics.
Agendia has tapped Al Luderer to serve on its supervisory board. Luderer is CEO of BioTrove, and he is on the scientific advisory board at Washington University's Department of Biomedical Engineering. He formerly was CEO of Light Sciences Corporation, and he has been COO at BioMerieux. He also previously served as VP of technology development and support at Boehringer Mannheim.